Zacks Investment Research on MSN

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Caribou Biosciences Reports Positive ANTLER Phase 1 Results

Detailed price information for Caribou Biosciences Inc (CRBU-Q) from The Globe and Mail including charting and trades.

This Biotech's Stock Price More Than Doubled on Friday. Here's Why.

Merck agreed to pay $9.2 billion to purchase Cidara Therapeutics, looking to cash in on the firm's experimental flu treatment.

Analysts Offer Insights on Healthcare Companies: Caribou Biosciences (CRBU), Santhera Pharmaceuticals Holding (OtherSPHDF) and BioCryst (BCRX)

Detailed price information for Biocryst Pharma Inc (BCRX-Q) from The Globe and Mail including charting and trades.